Category - Drug discovery

The Role of the Human Gut Microbiome in Alzheimer’s Disease Development

Alzheimer’s disease (AD), today is the most prevalent form of dementia afflicting more than 50 million people worldwide (Queiroz et al., 2022, Varesi et al., 2022), and with a doubling time of 20 years could easily...read more

Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine

My most recent interview is with Gavin Nichols, the CEO of the newly formed company Velsera. Velsera launched in January 2023, after quietly acquiring the three companies Seven Bridges, UgenTec, and Pierian in mid...read more

ONTOFORCE Wants to Increase Data Literacy and Empower Citizen Data Scientists

This month’s “Company Spotlight” provides a closer look at ONTOFORCE, the creator of a semantic search technology platform for insight generation. I spoke with Valerie Morel, CEO of ONTOFORCE, about ONTOFORCE’s platform...read more

Deepcell Aims to Create a Single Cell Morpholome Platform

We Invite you to join enlightenbio’s Subject Matter Expert Network!

enlightenbio is a boutique consultancy providing product strategy and market intelligence to precision medicine industries. Our mission is to help our clients successfully develop, launch, and market exceptional...read more

Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Data

HiberCell Expands Translational Oncology Toolbox by Acquiring Genuity Science, Inc.

Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing

FAIR Data or the Journey Towards Data-Centricity – Pushing Towards Making Data Discoverable, Accessible, Interoperable, and Reusable

GATC Health and Liquid Biosciences Partner to Improve Drug Development & Precision Medicine Research

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Category - Drug discovery

The Role of the Human Gut Microbiome in Alzheimer’s Disease Development

Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine

ONTOFORCE Wants to Increase Data Literacy and Empower Citizen Data Scientists

Deepcell Aims to Create a Single Cell Morpholome Platform

We Invite you to join enlightenbio’s Subject Matter Expert Network!

Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Data

HiberCell Expands Translational Oncology Toolbox by Acquiring Genuity Science, Inc.

Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing

GATC Health and Liquid Biosciences Partner to Improve Drug Development & Precision Medicine Research

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute

Mission Bio Raises $70M in Series C Funding Led by Novo Holdings to Accelerate Development of Cancer Therapies with Single-cell Multi-omics

Atomwise Raises $123 Million in Series B Financing Co-Led by B Capital Group and Sanabil

Genuity Science Announces Strategic Collaboration with Nashville Biosciences

Genomics England launches next-generation research platform central to UK COVID-19 response

WuXi NextCODE Restructures and Becomes Genuity Science

Archived news – SARS-CoV-2 vaccine development

Regeneron And Colorado Center For Personalized Medicine Announce Major New Human Genetics Research Collaboration